Great Tree Pharmacy Co Ltd
Great Tree Pharmacy Co., Ltd. engages in management and trading of drugs, health supplements, maternity and infant products, and cosmetics products in Taiwan, Mainland China, and Malaysia. The company also provides coordinated medicine procurement services to various clinics, outpatient centers, medical communities. In addition, it engages in the wholesale and retail business and packaging and wa… Read more
Great Tree Pharmacy Co Ltd (6469) - Net Assets
Latest net assets as of December 2025: NT$4.00 Billion TWD
Based on the latest financial reports, Great Tree Pharmacy Co Ltd (6469) has net assets worth NT$4.00 Billion TWD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$13.76 Billion) and total liabilities (NT$9.76 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$4.00 Billion |
| % of Total Assets | 29.07% |
| Annual Growth Rate | 26.67% |
| 5-Year Change | 104.89% |
| 10-Year Change | 443.22% |
| Growth Volatility | 17.97 |
Great Tree Pharmacy Co Ltd - Net Assets Trend (2012–2025)
This chart illustrates how Great Tree Pharmacy Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Great Tree Pharmacy Co Ltd (2012–2025)
The table below shows the annual net assets of Great Tree Pharmacy Co Ltd from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | NT$4.00 Billion | +9.65% |
| 2024-12-31 | NT$3.65 Billion | +8.86% |
| 2023-12-31 | NT$3.35 Billion | +27.68% |
| 2022-12-31 | NT$2.62 Billion | +34.43% |
| 2021-12-31 | NT$1.95 Billion | +28.49% |
| 2020-12-31 | NT$1.52 Billion | +24.30% |
| 2019-12-31 | NT$1.22 Billion | +13.65% |
| 2018-12-31 | NT$1.08 Billion | +33.35% |
| 2017-12-31 | NT$806.65 Million | +9.54% |
| 2016-12-31 | NT$736.42 Million | +36.04% |
| 2015-12-31 | NT$541.35 Million | +11.93% |
| 2014-12-31 | NT$483.65 Million | +72.80% |
| 2013-12-31 | NT$279.89 Million | +51.13% |
| 2012-12-31 | NT$185.19 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Great Tree Pharmacy Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1961.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$637.31 Million | 16.27% |
| Other Components | NT$3.28 Billion | 83.73% |
| Total Equity | NT$3.92 Billion | 100.00% |
Great Tree Pharmacy Co Ltd Competitors by Market Cap
The table below lists competitors of Great Tree Pharmacy Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
INVESTAR HLDG CORP. DL 1
F:7ZH
|
$209.27 Million |
|
LCNB Corporation
NASDAQ:LCNB
|
$209.28 Million |
|
ESSA Bancorp Inc
NASDAQ:ESSA
|
$209.29 Million |
|
Perma-Pipe International Holdings Inc
NASDAQ:PPIH
|
$209.32 Million |
|
Jiangsu Huachen Transformer
SHG:603097
|
$209.14 Million |
|
KERRY LOG.NETWORK HD-50
F:KYL
|
$209.11 Million |
|
Dhanuka Agritech Limited
NSE:DHANUKA
|
$209.08 Million |
|
Ascletis Pharma Inc
PINK:ASCLF
|
$209.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Great Tree Pharmacy Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,596,622,000 to 3,918,181,000, a change of 321,559,000 (8.9%).
- Net income of 600,421,000 contributed positively to equity growth.
- Dividend payments of 436,718,000 reduced retained earnings.
- New share issuances of 15,874,000 increased equity.
- Other factors increased equity by 141,982,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$600.42 Million | +15.32% |
| Dividends Paid | NT$436.72 Million | -11.15% |
| Share Issuances | NT$15.87 Million | +0.41% |
| Other Changes | NT$141.98 Million | +3.62% |
| Total Change | NT$- | 8.94% |
Book Value vs Market Value Analysis
This analysis compares Great Tree Pharmacy Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.17x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 26.06x to 3.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | NT$3.19 | NT$83.10 | x |
| 2013-12-31 | NT$3.96 | NT$83.10 | x |
| 2014-12-31 | NT$5.04 | NT$83.10 | x |
| 2015-12-31 | NT$5.44 | NT$83.10 | x |
| 2016-12-31 | NT$6.94 | NT$83.10 | x |
| 2017-12-31 | NT$7.55 | NT$83.10 | x |
| 2018-12-31 | NT$8.62 | NT$83.10 | x |
| 2019-12-31 | NT$10.82 | NT$83.10 | x |
| 2020-12-31 | NT$13.72 | NT$83.10 | x |
| 2021-12-31 | NT$17.13 | NT$83.10 | x |
| 2022-12-31 | NT$22.78 | NT$83.10 | x |
| 2023-12-31 | NT$27.79 | NT$83.10 | x |
| 2024-12-31 | NT$27.27 | NT$83.10 | x |
| 2025-12-31 | NT$26.18 | NT$83.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Great Tree Pharmacy Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.32%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.18%
- • Asset Turnover: 1.37x
- • Equity Multiplier: 3.51x
- Recent ROE (15.32%) is below the historical average (17.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 18.25% | 3.71% | 3.01x | 1.64x | NT$15.27 Million |
| 2013 | 24.33% | 5.99% | 2.56x | 1.59x | NT$40.11 Million |
| 2014 | 19.82% | 5.77% | 2.13x | 1.61x | NT$47.49 Million |
| 2015 | 14.31% | 3.59% | 2.49x | 1.61x | NT$23.33 Million |
| 2016 | 12.61% | 3.31% | 2.19x | 1.74x | NT$19.22 Million |
| 2017 | 12.73% | 2.83% | 2.36x | 1.91x | NT$21.95 Million |
| 2018 | 10.08% | 2.16% | 2.13x | 2.19x | NT$828.40K |
| 2019 | 11.33% | 2.06% | 1.41x | 3.90x | NT$15.93 Million |
| 2020 | 12.96% | 2.25% | 1.44x | 4.01x | NT$44.38 Million |
| 2021 | 21.09% | 3.61% | 1.53x | 3.83x | NT$214.23 Million |
| 2022 | 26.92% | 4.81% | 1.44x | 3.89x | NT$440.04 Million |
| 2023 | 20.30% | 4.13% | 1.50x | 3.28x | NT$337.89 Million |
| 2024 | 18.93% | 3.94% | 1.42x | 3.37x | NT$321.10 Million |
| 2025 | 15.32% | 3.18% | 1.37x | 3.51x | NT$208.60 Million |
Industry Comparison
This section compares Great Tree Pharmacy Co Ltd's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $728,406,000
- Average return on equity (ROE) among peers: 12.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Great Tree Pharmacy Co Ltd (6469) | NT$4.00 Billion | 18.25% | 2.44x | $209.14 Million |
| Arich Enterprise Co Ltd (4173) | $1.21 Billion | 4.16% | 2.90x | $27.84 Million |
| MedFirst Healthcare Services lnc (4175) | $910.56 Million | 12.40% | 2.44x | $32.54 Million |
| MARX Biotech Co., Ltd. (7731) | $65.61 Million | 21.00% | 0.39x | $50.74 Million |